‘Less is more’ states NPS
February 18, 2014
NPS Medicinewise has released
it’s 16th Annual Evaluation Report,
with claims that a 7% relative
decrease in prescribing of highdose
statins and 10% decrease in
anti-dementia drugs are a positive
outcome for the group.
The results were subsequent to
two therapeutic programs: ’CVD
risk: guiding lipid management’
and ‘Balancing benefits and harms
of antipsychotic therapy’ claiming
that “there were improvements in
knowledge and practice changes
among health professionals.”
There were 22,349 unique health
professionals participating in NPS
MedicineWise programs during
the year, with 57% of registered
GPs participating in an NPS
MedicineWise intervention.
NPS MedicineWise also increased
its online presence with 1.2 million
visits to its website and 1.3 million
Twitter and Facebook views in the
2012-13 financial year.
NPS MedicineWise ceo Dr Lynn
Weekes says the report outlines the
organisation’s success in creating
both health and economic impacts.
“I’m proud of the good work we
have done in the past financial
year to enable people to make the
best decisions about medicines
and other medical choices to
achieve better health and economic
outcomes,” said Dr Weekes.
“I’d like to acknowledge the
tremendous work and effort that
goes into achieving these results
and thank NPS MedicineWise staff,
member organisations, program
partners, advisory groups and
many others who make this work
possible,” she added.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Feb 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Feb 14
